Prab: CSV import

2025-02-13T03:25:41Z

CSV import

← Older revision		Revision as of 03:25, 13 February 2025
Line 1:		Line 1:
	{{~~svg-image~~}}		{{DISPLAYTITLE:CDKL5}}
	~~'''CDKL5''' (Cyclin-Dependent Kinase-Like 5) is a~~ [[~~protein~~]] ~~that in humans~~ is ~~encoded by the ''CDKL5'' [[~~gene~~]]. This [[gene]] is located on~~ the ~~X [[chromosome]] and~~ is involved in ~~a range of critical [[cellular]] processes, including [[cell cycle]] regulation, [[neuronal]]~~ development, and ~~[[synaptic]]~~ function. Mutations in the ''CDKL5'' gene are associated with a rare [[~~genetic~~ disorder]] ~~known as CDKL5 Deficiency Disorder~~ (CDD), ~~which is~~ characterized by early-onset, ~~difficult-to-control~~ [[~~seizures~~]], and ~~severe~~ [[~~neurodevelopmental~~]] ~~impairment~~.
			==Overview==
			[[CDKL5]] is a gene that encodes the cyclin-dependent kinase-like 5 protein, which is involved in brain development and function. Mutations in the CDKL5 gene are associated with a rare neurodevelopmental disorder known as [[CDKL5 deficiency disorder]] (CDD), characterized by early-onset seizures, severe developmental delay, and intellectual disability.

			==Function==
			The CDKL5 protein is a serine/threonine kinase that plays a crucial role in the development and function of the central nervous system. It is involved in various cellular processes, including [[synaptic plasticity]], [[neuronal migration]], and [[axon guidance]]. The protein is predominantly expressed in the brain, particularly in regions associated with cognitive function and motor control.

	==Genetics==		==Genetics==
	The ''CDKL5'' gene is located on the X chromosome (Xp22), ~~which means that~~ the disorder primarily affects females, although males can also be affected. The ~~gene encodes a serine/threonine kinase that~~ is ~~believed to play a key role~~ in the ~~development~~ and ~~function of the~~ [[~~nervous system~~]]. ~~Mutations in ''CDKL5'' can lead to a loss of functional protein~~, ~~which disrupts normal cellular functions~~ and ~~contributes to the symptoms observed in CDD~~.		The CDKL5 gene is located on the X chromosome at Xp22.13. It consists of multiple exons and encodes a protein that is approximately 1030 amino acids in length. Mutations in the CDKL5 gene can lead to a loss of function or a reduction in the activity of the CDKL5 protein, resulting in the clinical manifestations of CDKL5 deficiency disorder.

			==CDKL5 Deficiency Disorder==
			[[File:CDKL5.svg\|thumb\|right\|Diagram of the CDKL5 protein structure]]
			CDKL5 deficiency disorder is a rare genetic condition that primarily affects females, although males can also be affected. The disorder is characterized by early-onset [[epileptic seizures]], often beginning in the first few months of life, and severe [[developmental delay]]. Other symptoms may include [[hypotonia]], [[gastrointestinal issues]], and [[sleep disturbances]].

	==~~Clinical Presentation~~==		===Symptoms===
	~~Individuals with CDKL5 Deficiency Disorder typically present with early~~-onset seizures ~~that begin in the first few months of life. These seizures are often resistant to traditional [[antiepileptic drugs]]. Beyond seizures, children with CDD may also experience significant~~ developmental delays, including impairments in motor skills, speech, and [[cognition]]. Some individuals may also have features of [[autism spectrum disorder]] (ASD), gastrointestinal issues, and sleep disturbances.		- Early-onset seizures
			- Severe developmental delay
			- Intellectual disability
			- Motor dysfunction
			- Visual impairment

	==Diagnosis==		===Diagnosis===
	Diagnosis of CDKL5 ~~Deficiency Disorder~~ is based on clinical ~~presentation and confirmed through [[~~genetic testing~~]] that identifies~~ mutations in the ''CDKL5'' gene. ~~Early diagnosis is crucial for managing symptoms and improving~~ the ~~quality~~ of ~~life for affected individuals~~.		Diagnosis of CDKL5 deficiency disorder is based on clinical evaluation, genetic testing, and the identification of mutations in the CDKL5 gene. Genetic testing can confirm the presence of pathogenic variants that are known to cause the disorder.

	==~~Treatment~~==		===Management===
	There is currently no cure for CDKL5 ~~Deficiency Disorder. Treatment focuses on managing symptoms, particularly seizures, through a combination of antiepileptic drugs, [[ketogenic diet]]~~, and~~, in some cases,~~ [[~~surgical interventions~~]]. Physical~~, occupational, and speech therapies are also important for addressing developmental delays and improving functional abilities.~~		There is currently no cure for CDKL5 deficiency disorder, and treatment is primarily supportive and symptomatic. Management strategies may include:
			- [[Antiepileptic drugs]] to control seizures
			- Physical therapy to improve motor skills
			- Occupational therapy to enhance daily living skills
			- Speech therapy to address communication difficulties

	==Research==		==Research==
	~~Research~~ on ~~CDKL5 is ongoing, with studies aimed at~~ understanding the ~~precise functions of the~~ CDKL5 ~~protein, how mutations lead to disease,~~ and developing targeted therapies. ~~Gene~~ therapy and other ~~novel~~ approaches ~~are being explored as potential treatments~~ for ~~CDD~~.		Ongoing research is focused on understanding the molecular mechanisms underlying CDKL5 deficiency disorder and developing targeted therapies. Studies are exploring gene therapy, small molecule drugs, and other approaches to restore CDKL5 function or compensate for its loss.

			==Related pages==
			* [[Epilepsy]]
			* [[Neurodevelopmental disorder]]
			* [[Genetic disorder]]

	[[Category:Genetic disorders]]		[[Category:Genetic disorders]]
	[[Category:~~Neurological~~ disorders]]		[[Category:Neurodevelopmental disorders]]
	~~[[Category:Proteins]]~~
	~~{{medicine-stub}}~~

Prab: CSV import

2024-03-25T03:20:35Z

CSV import

New page

{{svg-image}}
'''CDKL5''' (Cyclin-Dependent Kinase-Like 5) is a [[protein]] that in humans is encoded by the ''CDKL5'' [[gene]]. This [[gene]] is located on the X [[chromosome]] and is involved in a range of critical [[cellular]] processes, including [[cell cycle]] regulation, [[neuronal]] development, and [[synaptic]] function. Mutations in the ''CDKL5'' gene are associated with a rare [[genetic disorder]] known as CDKL5 Deficiency Disorder (CDD), which is characterized by early-onset, difficult-to-control [[seizures]], and severe [[neurodevelopmental]] impairment.

==Genetics==
The ''CDKL5'' gene is located on the X chromosome (Xp22), which means that the disorder primarily affects females, although males can also be affected. The gene encodes a serine/threonine kinase that is believed to play a key role in the development and function of the [[nervous system]]. Mutations in ''CDKL5'' can lead to a loss of functional protein, which disrupts normal cellular functions and contributes to the symptoms observed in CDD.

==Clinical Presentation==
Individuals with CDKL5 Deficiency Disorder typically present with early-onset seizures that begin in the first few months of life. These seizures are often resistant to traditional [[antiepileptic drugs]]. Beyond seizures, children with CDD may also experience significant developmental delays, including impairments in motor skills, speech, and [[cognition]]. Some individuals may also have features of [[autism spectrum disorder]] (ASD), gastrointestinal issues, and sleep disturbances.

==Diagnosis==
Diagnosis of CDKL5 Deficiency Disorder is based on clinical presentation and confirmed through [[genetic testing]] that identifies mutations in the ''CDKL5'' gene. Early diagnosis is crucial for managing symptoms and improving the quality of life for affected individuals.

==Treatment==
There is currently no cure for CDKL5 Deficiency Disorder. Treatment focuses on managing symptoms, particularly seizures, through a combination of antiepileptic drugs, [[ketogenic diet]], and, in some cases, [[surgical interventions]]. Physical, occupational, and speech therapies are also important for addressing developmental delays and improving functional abilities.

==Research==
Research on CDKL5 is ongoing, with studies aimed at understanding the precise functions of the CDKL5 protein, how mutations lead to disease, and developing targeted therapies. Gene therapy and other novel approaches are being explored as potential treatments for CDD.

[[Category:Genetic disorders]]
[[Category:Neurological disorders]]
[[Category:Proteins]]
{{medicine-stub}}

CDKL5 - Revision history

Prab: CSV import

Prab: CSV import